Potential Savings From Greater Use of $4 Generic Drugs

被引：20

作者：

Zhang, Yuting ^{[1
]}

Zhou, Lei ^{[1
]}

Gellad, Walid F. ^{[2
,3
]}

机构：

[1] Univ Pittsburgh, Dept Hlth Policy & Management, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA

[2] Univ Pittsburgh, Sch Med, VA Pittsburgh Healthcare Syst, Div Gen Med, Pittsburgh, PA 15261 USA

[3] RAND Corp, Santa Monica, CA 90406 USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 2011年 / 171卷 / 05期

关键词：

D O I：

10.1001/archinternmed.2011.46

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：468 / 469

页数：2

共 50 条

[1] Needed Assumptions for Potential Savings From Greater Use of $4 Generic Drugs
Huesch, Marco D.
[J]. ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (17) : 1594 - 1595
[2] POTENTIAL SAVINGS FROM BROAD USE OF $4 GENERIC DRUGS: 2007 MEDICAL EXPENDITURE PANEL SURVEY
Zhang, Y.
Zhou, L.
Gellad, W.
[J]. VALUE IN HEALTH, 2010, 13 (03) : A90 - A90
[3] The Challenges in Budgeting Potential Savings with the Launch of Generic Drugs
Kenney, James T.
[J]. AMERICAN HEALTH AND DRUG BENEFITS, 2019, 12 (07): : 341 - 342
[4] Greater Potential Cost Savings With Biosimilar Use
Yu, Benjamin
[J]. AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (05): : 378 - 378
[5] Proton pump-inhibitor : No potential for savings by generic drugs
Pressemitteilung, Nach einer
[J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2007, 45 (12): : 1352 - 1352
[6] Potential Medicare Part D Savings on Ophthalmic Generic Drugs
Collet, David A.
Urban, Matthew B.
Amin, Abha
[J]. JAMA OPHTHALMOLOGY, 2024, 142 (07) : 678 - 680
[7] Potential savings from generic prescribing and generic substitution in South Africa
Karim, SSA
Pillai, G
ZiqubuPage, TT
Cassimjee, MH
Morar, MS
[J]. HEALTH POLICY AND PLANNING, 1996, 11 (02) : 198 - 202
[8] Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit
Fischer, MA
Avorn, J
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (04) : 207 - 214
[9] Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company
Lalani, Hussain S.
Kesselheim, Aaron S.
Rome, Benjamin N.
[J]. ANNALS OF INTERNAL MEDICINE, 2022, 175 (07) : 1053 - 1055
[10] Potential savings from substituting generic drugs for brand-name drugs: Medical Expenditure Panel Survey, 1997-2000
Haas, JS
Phillips, KA
Gerstenberger, EP
Seger, AC
[J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (11) : 891 - 897

← 1 2 3 4 5 →